Pages that link to "Q35088241"

The following pages link to Ongoing coxsackievirus myocarditis is associated with increased formation and activity of myocardial immunoproteasomes (Q35088241):

Displaying 28 items.

• Targeting the ubiquitin-proteasome system in heart disease: the basis for new therapeutic strategies (Q27026951) (← links)
• Virus-induced dilated cardiomyopathy is characterized by increased levels of fibrotic extracellular matrix proteins and reduced amounts of energy-producing enzymes (Q34219925) (← links)
• Proteome dynamics and proteome function of cardiac 19S proteasomes (Q34994354) (← links)
• Bioinformatics multivariate analysis determined a set of phase-specific biomarker candidates in a novel mouse model for viral myocarditis (Q35096144) (← links)
• PA28 modulates antigen processing and viral replication during coxsackievirus B3 infection (Q36302442) (← links)
• PAR-1 contributes to the innate immune response during viral infection. (Q36638187) (← links)
• Protein degradation systems in viral myocarditis leading to dilated cardiomyopathy (Q37541537) (← links)
• Cardiac Function Remains Impaired Despite Reversible Cardiac Remodeling after Acute Experimental Viral Myocarditis (Q37703469) (← links)
• The role of the proteasome in heart disease (Q37788836) (← links)
• Heterogeneous cardiac proteasomes: mandated by diverse substrates? (Q37864471) (← links)
• Interferon-dependent immunoproteasome activity during mouse adenovirus type 1 infection (Q39454584) (← links)
• The mammalian target of rapamycin modulates the immunoproteasome system in the heart (Q40664320) (← links)
• The immunoproteasome controls the availability of the cardioprotective pattern recognition molecule Pentraxin3. (Q40906092) (← links)
• Cytokine-induced oxidative stress in cardiac inflammation and heart failure-how the ubiquitin proteasome system targets this vicious cycle (Q41544521) (← links)
• Interferon-γ causes cardiac myocyte atrophy via selective degradation of myosin heavy chain in a model of chronic myocarditis (Q42109729) (← links)
• Inhibition of coagulation factor Xa improves myocardial function during CVB3-induced myocarditis. (Q42236619) (← links)
• Connective tissue growth factor: a crucial cytokine-mediating cardiac fibrosis in ongoing enterovirus myocarditis (Q42518607) (← links)
• Differential interferon responses enhance viral epitope generation by myocardial immunoproteasomes in murine enterovirus myocarditis (Q42592117) (← links)
• The immunoproteasome-specific inhibitor ONX 0914 reverses susceptibility to acute viral myocarditis (Q47558775) (← links)
• Myocardial inflammation, cellular death, and viral detection in sudden infant death caused by SIDS, suffocation, or myocarditis (Q48406305) (← links)
• Antigen-presentation capacity of dendritic cells is impaired in ongoing enterovirus myocarditis. (Q52894988) (← links)
• Viral myocarditis and coagulopathy: increased tissue factor expression and plasma thrombogenicity. (Q52918359) (← links)
• Silencing the CSF-1 Axis Using Nanoparticle Encapsulated siRNA Mitigates Viral and Autoimmune Myocarditis (Q57817469) (← links)
• Proteasomal Protein Degradation: Adaptation of Cellular Proteolysis With Impact on Virus-and Cytokine-Mediated Damage of Heart Tissue During Myocarditis (Q59804795) (← links)
• Non-antigen processing immunoproteasomes in diabetic hearts? (Q84036275) (← links)
• Coxsackievirus B5 induced apoptosis of HeLa cells: effects on p53 and SUMO (Q84886047) (← links)
• Protein modification with ISG15 blocks coxsackievirus pathology by antiviral and metabolic reprogramming (Q90485218) (← links)
• Proteasomes and Several Aspects of Their Heterogeneity Relevant to Cancer (Q92923068) (← links)